Frédéric Gilbert Labéguére

Title: Frédéric Gilbert Labéguére: Innovator in Pharmaceutical Compounds

Introduction

Frédéric Gilbert Labéguére is a notable inventor based in Gagny, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating inflammatory disorders. His innovative work has led to the creation of a patent that addresses critical health issues.

Latest Patents

Labéguére holds a patent for "Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders." This patent describes a compound that antagonizes GPR84, a G-protein-coupled receptor involved in various inflammatory conditions. The invention outlines methods for producing these novel compounds and their applications in treating diseases such as inflammatory bowel diseases, rheumatoid arthritis, and chronic obstructive pulmonary disease, among others.

Career Highlights

Frédéric Gilbert Labéguére is associated with Galapagos NV, a company known for its focus on innovative medicines. His work at Galapagos has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in creating compounds that target inflammatory conditions showcases his commitment to advancing medical science.

Collaborations

Labéguére has collaborated with notable colleagues, including Gregory John Robert Newsome and Luke Jonathan Alvey. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to innovative solutions in healthcare.

Conclusion

Frédéric Gilbert Labéguére's contributions to pharmaceutical innovations are significant, particularly in the realm of treating inflammatory disorders. His patent and work at Galapagos NV highlight his dedication to improving health outcomes through scientific advancements.